Eva Ringdal Pedersen

ORCID: 0000-0002-2545-1866
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Folate and B Vitamins Research
  • Diet and metabolism studies
  • Tryptophan and brain disorders
  • Nutritional Studies and Diet
  • Lipoproteins and Cardiovascular Health
  • Cardiac Imaging and Diagnostics
  • Fatty Acid Research and Health
  • Metabolism and Genetic Disorders
  • Cardiovascular Disease and Adiposity
  • Stress Responses and Cortisol
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Liver Disease Diagnosis and Treatment
  • Acute Myocardial Infarction Research
  • Peroxisome Proliferator-Activated Receptors
  • Cardiovascular Function and Risk Factors
  • Metabolomics and Mass Spectrometry Studies
  • GDF15 and Related Biomarkers
  • Eicosanoids and Hypertension Pharmacology
  • Adipokines, Inflammation, and Metabolic Diseases
  • Vitamin C and Antioxidants Research
  • Bipolar Disorder and Treatment
  • Gut microbiota and health
  • Vitamin D Research Studies
  • Diet, Metabolism, and Disease
  • Cancer, Lipids, and Metabolism

University of Bergen
2014-2025

Haukeland University Hospital
2016-2025

RELX Group (United States)
2024

Institute of Social and Preventive Medicine
2021

University of Bern
2021

University of South Australia
2014-2020

Bevital (Norway)
2010-2016

Norwegian Institute of Public Health
2012-2016

Stavanger University Hospital
2010-2014

Maastricht University
2014

The aim was to study the prognostic value of plasma ceramides (Cer) as cardiovascular death (CV death) markers in three independent coronary artery disease (CAD) cohorts.Corogene is a prospective Finnish cohort including stable CAD patients (n = 160). Multiple lipid biomarkers and C-reactive protein were measured addition Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/24:0), Cer(d18:1/24:1). Subsequently, association between high-risk CV mortality investigated Special Program University...

10.1093/eurheartj/ehw148 article EN cc-by European Heart Journal 2016-04-28

<h3>Context</h3>Observational studies have reported associations between circulating total homocysteine concentration and risk of cardiovascular disease. Oral administration folic acid vitamin B<sub>12</sub> can lower plasma levels.<h3>Objective</h3>To assess the effect treatment with B<sub>6</sub> as secondary prevention in patients coronary artery disease or aortic valve stenosis.<h3>Design, Setting, Participants</h3>Randomized, double-blind controlled trial conducted 2 university...

10.1001/jama.300.7.795 article EN JAMA 2008-08-19

Objective— Enhanced tryptophan degradation, induced by the proinflammatory cytokine interferon-γ, has been related to cardiovascular disease progression and insulin resistance. We assessed downstream metabolites of kynurenine pathway as predictors acute myocardial infarction in patients with suspected stable angina pectoris. Furthermore, we evaluated potential effect modifications according diagnoses pre-diabetes mellitus or diabetes mellitus. Approach Results— Blood samples were obtained...

10.1161/atvbaha.114.304674 article EN Arteriosclerosis Thrombosis and Vascular Biology 2014-12-19
Stephen Zewinger Marcus E. Kleber Vinicius Tragante Raymond O. McCubrey Amand F. Schmidt and 95 more Kenan Direk Ulrich Laufs Christian Werner Wolfgang Köenig Dietrich Rothenbacher Ute Mons Lutz P. Breitling Hermann Brenner Richard T. Jennings Ioannis Petrakis Sarah Triem Mira Klug Alexandra Filips Stefan Blankenberg Christoph Waldeyer Christoph Sinning Renate B. Schnabel Karl J. Lackner Efthymia Vlachopoulou Ottar Nygård Gard Frodahl Tveitevåg Svingen Eva Ringdal Pedersen Grethe S. Tell Juha Sinisalo Markku S. Nieminen Reijo Laaksonen Stella Trompet Roelof A.J. Smit Naveed Sattar J. Wouter Jukema Heinrich V. Groesdonk Graciela Delgado Tatjana Stojaković Anna P. Pilbrow Vicky A. Cameron Mark Richards Robert N. Doughty Yan Gong Rhonda M. Cooper‐DeHoff Julie A. Johnson Markus Scholz Frank Beutner Joachim Thiery J. G. Smith Ragnar O. Vilmundarson Ruth McPherson Alexandre F.R. Stewart Sharon Cresci Petra Lenzini John A. Spertus Oliviero Olivieri Domenico Girelli Nicola Martinelli Andreas Leiherer Christoph H. Saely Heinz Drexel Axel Mündlein Peter S. Braund Christopher P. Nelson Nilesh J. Samani Daniel Kofink Imo E. Hoefer Gerard Pasterkamp Arshed A. Quyyumi Yi-An Ko Jaana Hartiala Hooman Allayee W.H. Wilson Tang Stanley L. Hazen Niclas Eriksson Claes Held Emil Hagström Lars Wallentin Axel Åkerblom Agneta Siegbahn Igor Karp Christopher Labos Louise Pilote James C. Engert James M. Brophy George Thanassoulis Peter Bogaty Wojciech Szczeklik Marcin Kaczor Marek Sanak Salim S. Virani Christie M. Ballantyne Vei-Vei Lee Eric Boerwinkle Michael V. Holmes Benjamin D. Horne Aroon D. Hingorani Folkert W. Asselbergs Riyaz Patel Bernhard K. Krämer

10.1016/s2213-8587(17)30096-7 article EN The Lancet Diabetes & Endocrinology 2017-05-29

Interferon γ (IFN-γ) is centrally involved in atherosclerosis-related inflammation, but its activity cannot be reliably assessed by systemic measurements. In activated macrophages, IFN-γ stimulates production of neopterin and conversion tryptophan to kynurenine. We evaluated the relationships plasma kynurenine:tryptophan ratio (KTR) long-term prognosis patients with stable angina pectoris angiographically verified significant coronary artery disease.Samples were obtained from 2380 a mean age...

10.1161/atvbaha.110.219329 article EN Arteriosclerosis Thrombosis and Vascular Biology 2010-12-24

Dimethylglycine is linked to lipid metabolism, and increased plasma levels may be associated with adverse prognosis in patients coronary artery disease. We evaluated the relationship between dimethylglycine risk of incident acute myocardial infarction a large prospective cohort stable angina pectoris, whom approximately two thirds were participants B-vitamin intervention trial. Model discrimination reclassification when adding established factors obtained. also explored temporal changes...

10.1161/atvbaha.113.301714 article EN Arteriosclerosis Thrombosis and Vascular Biology 2013-05-31

Several compounds in the choline oxidation pathway are associated with insulin resistance and prevalent diabetes; however, prospective data scarce.We explored relationships between systemic urinary choline-related metabolites incident type 2 diabetes an observational study among Norwegian patients.We risk associations by logistic regression 3621 nondiabetic individuals suspected stable angina pectoris, of whom 3242 provided urine samples. Reclassification patients was investigated according...

10.1373/clinchem.2015.250761 article EN Clinical Chemistry 2016-03-15

Excess levels of serum acylcarnitines, which are intermediate products in metabolism, have been observed metabolic diseases such as type 2 diabetes mellitus. However, it is not known whether acylcarnitines may prospectively predict risk cardiovascular death or acute myocardial infarction patients with stable angina pectoris.This study included 4164 (median age, 62 years; 72% men). Baseline acetyl-, octanoyl-, palmitoyl-, propionyl-, and (iso)valerylcarnitine were measured using liquid...

10.1161/jaha.116.003620 article EN cc-by-nc-nd Journal of the American Heart Association 2017-02-02

Kynurenine is a potent endothelium-derived vasodilator. Its synthesis from tryptophan stimulated by interferon γ and may represent an important compensatory pathway for the regulation of vascular function in inflammatory conditions. We assessed associations urine kynurenine to ratio (KTR) levels incident major coronary events (MCEs), acute myocardial infarction (AMI), ischaemic stroke mortality patients with suspected stable artery disease (CAD). A total 3224 (mean age 62 years, 69% men)...

10.1093/eurheartj/eht264 article EN European Heart Journal 2013-07-25

The tryptophan metabolite kynurenine has potent immune modulatory and vasoactive properties. Experimental data implicate in obesity-related morbidities. Epidemiological studies are, however, sparse. We evaluated associations of the plasma urine kynurenine:tryptophan ratio (KTR) to incident type 2 diabetes. followed 2519 individuals with coronary artery disease (CAD; 73.1% men) without diabetes at baseline for a median 7.6 years, during which 173 (6.9%) new incidences were identified....

10.1007/s00125-017-4329-9 article EN cc-by Diabetologia 2017-06-13

Summary Effective strategies are needed to help individuals lose weight and maintain loss. The primary aim of this study was investigate the effect intermittent energy restriction ( IER ) compared continuous CER on loss after 8 weeks maintenance 12 months. Secondary aims were determine changes in waist hip measurements diet quality. In a randomized parallel study, overweight obese (body mass index [ BMI ] ≥ 27 kg m −2 women stratified by age before randomization. Participants undertook an...

10.1111/cob.12052 article EN Clinical Obesity 2014-03-06

Background Metabolites of the kynurenine pathway (mKP) relate to important aspects heart failure pathophysiology, such as inflammation, energy-homeostasis, apoptosis, and oxidative stress. We aimed investigate whether mKP predict mortality in patients with failure. Methods The study included 202 (73.8% coronary artery disease (CAD)), propensity score matched 384 controls without disease, 807 CAD (71%). All underwent angiography ventriculography at baseline. Plasma mKP, pyridoxal 5'phosphate...

10.1371/journal.pone.0227365 article EN cc-by PLoS ONE 2020-01-10
Coming Soon ...